» Articles » PMID: 15929698

Lymphoid Follicles Are Sites of Heightened Human Immunodeficiency Virus Type 1 (HIV-1) Replication and Reduced Antiretroviral Effector Mechanisms

Overview
Publisher Mary Ann Liebert
Date 2005 Jun 3
PMID 15929698
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

The observation that HIV-1 replication is concentrated in lymphoid follicles (F) compared to extrafollicular (EF) lymphoid tissue is not fully understood. The purpose of this study was to quantify HIV-1 replication in these compartments and evaluate the hypothesis that heightened replication in F occurs because of diminished antiretroviral mechanisms. In situ hybridization for HIV-1 RNA and immunohistochemical staining for CD4, CD8, CD20, and multiple antiretroviral proteins was performed in lymph nodes from 15 HIV-1-infected individuals who were not receiving antiretroviral therapy. A median of 70% of virus-producing cells were detected in F, defined morphologically by CD20 staining, although only a minority of tissue (median, 19%) consisted of F. Frequencies of virus-producing cells were higher in F (median, 1.35 cells/mm2) compared to EF (median, 0.35 cells/mm2; p < 0.0001). A CD4+ cell in F had a median 31-fold greater likelihood of harboring HIV-1 RNA than a CD4+ cell in EF (p = 0.0006). The most highly expressed antiretroviral proteins were alpha-defensins 1, 2, and 3 (median, 4.6% tissue staining), RANTES (median, 728.4 cells/mm2), and granzyme A (median, 412.6 cells/mm2). Less alpha-defensins (p = 0.0127), RANTES (p = 0.0007), granzyme A (p = 0.0018), MIP-1alpha (p = 0.0054), interferon (IFN)-alpha (p = 0.0186), and CD8 (p < 0.0001) was expressed in F compared to EF; amounts in F ranged from 0.15 to 0.50 of those in EF. Expression of IFN-gamma (median, 3.1 cells/mm2) and perforin (median, 4.0 cells/mm2) was low and not significantly different in F and EF. Deficiencies of multiple antiretroviral proteins within F may contribute to heightened replication at that site.

Citing Articles

Compartmental structure in the secondary lymphoid tissue can slow down HIV-1 evolution in the presence of strong CTL responses.

Chung W, Wodarz D J R Soc Interface. 2025; 22(223):20240468.

PMID: 39999881 PMC: 11858754. DOI: 10.1098/rsif.2024.0468.


Energy demanding RNA and protein metabolism drive dysfunctionality of HIV-specific T cell changes during chronic HIV infection.

van Pul L, Stunnenberg M, Kroeze S, van Dort K, Boeser-Nunnink B, Harskamp A PLoS One. 2024; 19(10):e0298472.

PMID: 39356699 PMC: 11446443. DOI: 10.1371/journal.pone.0298472.


Efficacy and safety of novel multifunctional M10 CAR-T cells in HIV-1-infected patients: a phase I, multicenter, single-arm, open-label study.

Mao Y, Liao Q, Zhu Y, Bi M, Zou J, Zheng N Cell Discov. 2024; 10(1):49.

PMID: 38740803 PMC: 11091177. DOI: 10.1038/s41421-024-00658-z.


Human immunodeficiency virus dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte escape mutants.

Chung W, Connick E, Wodarz D Virus Evol. 2024; 10(1):vead084.

PMID: 38516655 PMC: 10956502. DOI: 10.1093/ve/vead084.


Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles.

Malyshkina A, Bayer W, Podschwadt P, Otto L, Karakoese Z, Sutter K PLoS Pathog. 2023; 19(10):e1011725.

PMID: 37883584 PMC: 10602292. DOI: 10.1371/journal.ppat.1011725.